| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8437555 | EBioMedicine | 2018 | 6 Pages | 
Abstract
												Naturally occurring genetic variation in the dopamine system can influence treatment outcomes in children with cerebral palsy. A polygenic dopamine score might be valid for treatment outcome prediction and for designing individually tailored interventions for children with cerebral palsy.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Rochellys Diaz Heijtz, Rita Almeida, Ann Christin Eliasson, Hans Forssberg, 
											